Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Melanoma initiating cells: where do we stand?

Literature DB >> 30190839

Melanoma initiating cells: where do we stand?

Vincenzo Villani^1,1, Francesco Sabbatino^1,1, Cristina R Ferrone^1,1, Soldano Ferrone^1,2,1,2.

Abstract

Entities: Disease

Keywords: cancer initiating cells; cancer stem cells; melanoma; melanoma initiating cells

Year: 2015 PMID： 30190839 PMCID： PMC6094641 DOI： 10.2217/mmt.15.2

Source DB: PubMed Journal: Melanoma Manag ISSN： 2045-0885

× No keyword cloud information.

24 in total

Review 1. The hitchhikers guide to cancer stem cell theory: markers, pathways and therapy.

Authors: Ákos Fábián; György Vereb; János Szöllősi
Journal: Cytometry A Date: 2012-09-20 Impact factor: 4.355

2. VEGFR-1 expressed by malignant melanoma-initiating cells is required for tumor growth.

Authors: Natasha Y Frank; Tobias Schatton; Soo Kim; Qian Zhan; Brian J Wilson; Jie Ma; Karim R Saab; Veronika Osherov; Hans R Widlund; Martin Gasser; Ana-Maria Waaga-Gasser; Thomas S Kupper; George F Murphy; Markus H Frank
Journal: Cancer Res Date: 2011-01-06 Impact factor: 12.701

3. Melanoma contains CD133 and ABCG2 positive cells with enhanced tumourigenic potential.

Authors: Elena Monzani; Floriana Facchetti; Enrico Galmozzi; Elena Corsini; Anna Benetti; Chiara Cavazzin; Angela Gritti; Andrea Piccinini; Danilo Porro; Mario Santinami; Gloria Invernici; Eugenio Parati; Giulio Alessandri; Caterina A M La Porta
Journal: Eur J Cancer Date: 2007-02-22 Impact factor: 9.162

4. Targeting CD20 in melanoma patients at high risk of disease recurrence.

Authors: Alice Pinc; Rajasekharan Somasundaram; Christine Wagner; Marcus Hörmann; Georgios Karanikas; Ahmad Jalili; Wolfgang Bauer; Patrick Brunner; Katharina Grabmeier-Pfistershammer; Melanie Gschaider; Chiou-Yan Lai; Mei-Yu Hsu; Meenhard Herlyn; Georg Stingl; Stephan N Wagner
Journal: Mol Ther Date: 2012-02-21 Impact factor: 11.454

5. Identification of cells initiating human melanomas.

Authors: Tobias Schatton; George F Murphy; Natasha Y Frank; Kazuhiro Yamaura; Ana Maria Waaga-Gasser; Martin Gasser; Qian Zhan; Stefan Jordan; Lyn M Duncan; Carsten Weishaupt; Robert C Fuhlbrigge; Thomas S Kupper; Mohamed H Sayegh; Markus H Frank
Journal: Nature Date: 2008-01-17 Impact factor: 49.962

6. Human melanoma-initiating cells express neural crest nerve growth factor receptor CD271.

Authors: Alexander D Boiko; Olga V Razorenova; Matt van de Rijn; Susan M Swetter; Denise L Johnson; Daphne P Ly; Paris D Butler; George P Yang; Benzion Joshua; Michael J Kaplan; Michael T Longaker; Irving L Weissman
Journal: Nature Date: 2010-07-01 Impact factor: 49.962

7. ALDH1A isozymes are markers of human melanoma stem cells and potential therapeutic targets.

Authors: Yuchun Luo; Katiuscia Dallaglio; Ying Chen; William A Robinson; Steven E Robinson; Martin D McCarter; Jianbin Wang; Rene Gonzalez; David C Thompson; David A Norris; Dennis R Roop; Vasilis Vasiliou; Mayumi Fujita
Journal: Stem Cells Date: 2012-10 Impact factor: 6.277

Review 2. Aldehyde dehydrogenase-positive melanoma stem cells in tumorigenesis, drug resistance and anti-neoplastic immunotherapy.

Authors: Simin Zhang; Zhen Yang; Fazhi Qi
Journal: Mol Biol Rep Date: 2019-12-14 Impact factor: 2.316

2 in total

Melanoma initiating cells: where do we stand?

Review 1. The hitchhikers guide to cancer stem cell theory: markers, pathways and therapy.

2. VEGFR-1 expressed by malignant melanoma-initiating cells is required for tumor growth.

3. Melanoma contains CD133 and ABCG2 positive cells with enhanced tumourigenic potential.

4. Targeting CD20 in melanoma patients at high risk of disease recurrence.

5. Identification of cells initiating human melanomas.

6. Human melanoma-initiating cells express neural crest nerve growth factor receptor CD271.

7. ALDH1A isozymes are markers of human melanoma stem cells and potential therapeutic targets.

8. SOX2 regulates self-renewal and tumorigenicity of human melanoma-initiating cells.

9. Efficient tumour formation by single human melanoma cells.

10. CD271 is an imperfect marker for melanoma initiating cells.

1. A Novel Regimen for Treating Melanoma: MCL1 Inhibitors and Azacitidine.

Review 2. Aldehyde dehydrogenase-positive melanoma stem cells in tumorigenesis, drug resistance and anti-neoplastic immunotherapy.